HUP1800332A1 - Tricyclic compounds ii - Google Patents
Tricyclic compounds iiInfo
- Publication number
- HUP1800332A1 HUP1800332A1 HU1800332A HUP1800332A HUP1800332A1 HU P1800332 A1 HUP1800332 A1 HU P1800332A1 HU 1800332 A HU1800332 A HU 1800332A HU P1800332 A HUP1800332 A HU P1800332A HU P1800332 A1 HUP1800332 A1 HU P1800332A1
- Authority
- HU
- Hungary
- Prior art keywords
- tricyclic compounds
- tricyclic
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1800332A HUP1800332A1 (en) | 2018-09-28 | 2018-09-28 | Tricyclic compounds ii |
| TW107144825A TW201938171A (en) | 2017-12-15 | 2018-12-12 | Tricyclic compounds as vasopressin V1a receptor antagonists |
| PCT/IB2018/060078 WO2019116325A1 (en) | 2017-12-15 | 2018-12-14 | Tricyclic compounds as vasopressin v1a receptor antagonists |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1800332A HUP1800332A1 (en) | 2018-09-28 | 2018-09-28 | Tricyclic compounds ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP1800332A1 true HUP1800332A1 (en) | 2020-04-28 |
Family
ID=89992763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1800332A HUP1800332A1 (en) | 2017-12-15 | 2018-09-28 | Tricyclic compounds ii |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP1800332A1 (en) |
-
2018
- 2018-09-28 HU HU1800332A patent/HUP1800332A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202207722B (en) | Substituted tricyclic compounds | |
| ZA202206253B (en) | Substituted tricyclic compounds | |
| GB201805174D0 (en) | Compounds | |
| GB201810092D0 (en) | Compounds | |
| GB201801355D0 (en) | Compounds | |
| GB201807924D0 (en) | Compounds | |
| GB201810581D0 (en) | Compounds | |
| ZA202100237B (en) | Tricyclic compounds | |
| IL282366A (en) | Tricyclic pesticidal compounds | |
| GB201814151D0 (en) | Compounds | |
| GB201808093D0 (en) | Compounds | |
| FI3810633T3 (en) | Compounds | |
| GB201809102D0 (en) | Compounds | |
| GB201817083D0 (en) | Compounds | |
| GB201810071D0 (en) | Compounds | |
| IL287813A (en) | Tricyclic compounds | |
| GB201803340D0 (en) | Compounds | |
| GB201818649D0 (en) | Compounds | |
| GB201818651D0 (en) | Compounds | |
| GB201814167D0 (en) | Compounds | |
| GB201812382D0 (en) | Compounds | |
| GB201801130D0 (en) | Compounds | |
| GB201801128D0 (en) | Compounds | |
| HUP1800332A1 (en) | Tricyclic compounds ii | |
| HUP1700522A1 (en) | Tricyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |